Bifidobacterium longum is a species of small pathogenic bacteria, which naturally occurs in gastrointestinal tracts of human and other animals. The bacterium is added to different types of foods, beverages, and dietary supplements as a probiotic, as it provides many health benefits such as improved digestion and bowel movements.

Market Analysis and Insights: Global Bifidobacterium Longum Market
The global Bifidobacterium Longum market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Bifidobacterium Longum Scope and Market Size
The global Bifidobacterium Longum market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bifidobacterium Longum market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
0.2g/Piece
0.25g/Piece

Segment by Application
Medicine
Others

The Bifidobacterium Longum market is analysed and market size information is provided by regions (countries). Segment by Application, the Bifidobacterium Longum market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
ATCC Inc
BioGaia AB
Mystic Pharmaceuticals Inc
Hanson Ltd
Biofodan A/S
BioCare Copenhagen ApS
Danisco A/S
Danone SA
Deerland Enzymes Inc.